Pharmaceutical Technology

JUNE 21, 2023

Participants treated with LODOCO had a 31% reduction in the overall risk of cardiovascular death, spontaneous myocardial infarction or ischaemic stroke when added to statins and other cardiology prevention therapies, compared to those treated with placebo.

FDA Approval 246

FDA Approval Cardiology Clinical Trials Clinical Trials 246

Medical Xpress

APRIL 18, 2023

Patients with severe COVID-19 requiring mechanical ventilation are 16 times more likely to develop ventricular tachycardia within six months compared to their peers without severe infection, according to research presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).

Cardiology 88

Cardiology Development Research 88

Velocity Clinical Research

MARCH 19, 2024

The summit focused on Velocity’s Diabetes + Obesity, MASH, Vaccine, Cardiology, and Women’s Health CARE Councils, along with a few areas in development.

Cardiology 52

Cardiology Clinical Trials Clinical Trials Clinical Development 52

STAT News

MARCH 6, 2023

NEW ORLEANS — Aptly or paradoxically, thousands of the world’s leading cardiologists descended on the home of beignets, bouillabaisse, and beers sold to-go for a weekend-long dive into the latest developments in the science of keeping hearts beating healthily.

Cardiology 98

Cardiology Gene Development Drugs 98

Medical Xpress

APRIL 27, 2023

A research team from Wake Forest University School of Medicine has developed an open-source, web-based application that allows users to generate customized hypertension statistics using National Health and Nutrition Examination Survey (NHANES) data.

Development 86

Development Research Medicine Cardiology 86

Scienmag

MAY 22, 2022

Madrid, Spain – 22 May 2022: Levels of alcohol consumption currently considered safe by some countries are linked with development of heart failure, according to research presented at Heart Failure 2022, a scientific congress of the European Society of Cardiology (ESC).1

Cardiology 77

Cardiology Development Research 77

Rethinking Clinical Trials

DECEMBER 20, 2023

Further efforts are urgently needed to increase diversity in the cardiology workforce, which will improve clinical trial diversity and cardiovascular health for all. Approaches from the whole scientific community to tackle the inequality in workforce, trial leadership and trial participants have to be developed.

Clinical Trials 169

Clinical Trials Clinical Trials Trials Cardiology 169

Scienmag

NOVEMBER 13, 2020

Smidt Heart Institute Chair of Cardiology presents new findings at American Heart Association Scientific Sessions Credit: Photo by Cedars-Sinai LOS ANGELES (Nov.

Cardiology 85

Cardiology Development Research Medicine 85

Medical Xpress

FEBRUARY 15, 2023

Traffic noise may play an essential role in the development and deterioration of ischemic heart disease.

Gene Expression 74

Gene Expression Cardiology Gene Research 74

Medical Xpress

DECEMBER 20, 2022

Using machine learning and clinical data from electronic health records, researchers at the Icahn School of Medicine at Mount Sinai in New York constructed an in silico, or computer-derived, marker for coronary artery disease (CAD) to better measure clinically important characterizations of the disease.

Development 145

Development Medicine Research Cardiology 145

Medical Xpress

FEBRUARY 1, 2023

Autism spectrum disorders may be associated with a higher risk for developing cardiometabolic diseases, according to a review published online Jan. 30 in JAMA Pediatrics.

Development 69

Development Cardiology 69

Medical Xpress

FEBRUARY 8, 2023

Rytis Maskeliūnas, a researcher at KTU's Faculty of Informatics, Lithuania together with an international team, has developed an app that will teach how to take care of a person who has suffered a stroke in a virtual environment. It is a condition that usually leaves the patient disabled, often requiring constant care.

Development 73

Development Research Cardiology 73

Scienmag

MARCH 19, 2022

Sophia Antipolis – 19 March 2022: Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to research presented today at ESC Acute CardioVascular Care 2022, a scientific congress of the European Society of Cardiology (ESC).1

Cardiology 61

Cardiology Development Research 61

Scienmag

JUNE 13, 2022

fold increased risk of developing hypertension 10 years post pregnancy compared to women who did not experience any hypertensive disorders of pregnancy (HDP), according to a study published today in the Journal of the American College of Cardiology. Women who experience gestational hypertension or preeclampsia have a 2.4-fold

Cardiology 56

Cardiology Development 56

Scienmag

OCTOBER 18, 2020

Beijing, China 19 Oct 2020: Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). Faculty from the European Society of Cardiology (ESC) will participate in joint scientific […].

Cardiology 43

Cardiology Development Research Medicine 43

BioPharma Reporter

MAY 23, 2023

Neurimmune has announced that primary results of its phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of the European Society of Cardiology (ESC), and published in The New England Journal of Medicine.

Cardiology 52

Cardiology Antibody Medicine Development 52

Medical Xpress

NOVEMBER 25, 2022

The University of Twente and its partners are developing a smart wearable to automatically and reliably detect out-of-hospital cardiac arrest (OHCA), and to trigger an immediate emergency response.

Development 74

Development Cardiology 74

Drug Discovery World

DECEMBER 20, 2023

The company has 155 investigators who perform trials in around 20 therapeutic areas, including infectious disease, neurology, endocrinology, oncology, cardiology, dermatology and vaccines.

Clinical Research 52

Clinical Research Research Cardiology Dermatology 52

Medical Xpress

JANUARY 4, 2023

In a new study by researchers from Mass General Brigham's founding members, Brigham and Women's Hospital and Massachusetts General Hospital, a team extensively investigated the immune response of 16 adolescents and young adults who developed myocarditis after receipt of the COVID mRNA vaccine.

Immune Response 91

Immune Response Protein Vaccination Vaccine 91

Rethinking Clinical Trials

JULY 19, 2023

This was a cluster-randomized trial of 42 cardiology clinics across the U.S., The cardiology clinics were randomized to one of two groups. It is essential to scale this intervention across cardiology practices in order to improve the quality of care being delivered more broadly to ensure the implementation of these trial results.

Trials 130

Trials Cardiology Medicine Nurses 130

The Pharma Data

MARCH 23, 2022

Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July. He also led the expansion of Merck’s research and development in China and Japan. “It Eliav Barr, senior vice president, Global Clinical Development.

Clinical Development 52

Clinical Development Development Vaccination Vaccine 52

Scienmag

JUNE 27, 2021

Sophia Antipolis – 28 June 2021: A study in more than 200,000 individuals has found that patients with heart failure are more likely to develop cancer compared to their peers without heart failure.

Cardiology 40

Cardiology Development Research Medicine 40

Medical Xpress

DECEMBER 16, 2022

Myocardial infarction is an ischemic disease in which a coronary artery supplying blood to the heart muscle is stenotic or obstructed, resulting in cardiac tissue necrosis. Due to the irreversible loss of cardiomyocytes, damaged heart tissue cannot be naturally regenerated.

Development 73

Development Research Cardiology 73

Rethinking Clinical Trials

FEBRUARY 14, 2024

DCP developed an EHR-based workflows and integrated workflows within the local VA primary care setting. DCP developed 3 electronic workflows with 6 major configurations including applications needed outside of the EHR system. DCP developed a patient tracking tool that nurses could use to make sure patients got through each step.

Clinical Trials 152

Clinical Trials Clinical Trials Cardiology Trials 152

STAT News

JANUARY 6, 2023

… Pfizer told employees it plans to pull back on early-stage research into treatments for rare diseases, including the development of new viral-based gene therapies , Barron’s reports. Among the assets on the chopping block is a gene therapy manufacturing facility in Durham, N.C.,

Gene Therapy 98

Gene Therapy Trials Research Cardiology 98

Scienmag

APRIL 22, 2021

of the Division of Cardiovascular Medicine, Department of Internal Medicine) have developed an AI that uses multiple kinds of test data to predict the location of surplus pathways in the heart called ‘accessory pathways’, which cause the heart […].

Development 85

Development Medicine Cardiology Engineer 85

Velocity Clinical Research

NOVEMBER 21, 2023

“Without clinical research, there would be little if any development of new medicines,” says Isabelle Schenkenberger, MD. After graduating, she worked at the Auguste-Viktoria-Klinikum in internal medicine with a focus on cardiology, angiology, diabetology and emergency medicine from 1990 to 2004.

Medicine 59

Medicine Cardiology Clinical Research Clinical Trials 59

BioTech 365

SEPTEMBER 9, 2020

& SAN DIEGO–(BUSINESS WIRE)–$PHAS #Cardiology—PhaseBio Pharmaceuticals, Inc. Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases, today announced that Chief Executive Officer Jonathan P.

Cardiology 52

Cardiology Development 52

The Pharma Data

OCTOBER 31, 2020

With that in mind, the American College of Cardiology came up with some safety recommendations in May, which have now been revised. How many athletes with COVID-19 develop heart problems isn’t known, but the group said those who have moderate to severe coronavirus symptoms should be screened. 26 in JAMA Cardiology.

Cardiology 52

Cardiology Medicine Development 52

Drug Discovery World

SEPTEMBER 1, 2022

Individuals with an autoimmune disorder have a substantially higher risk of developing cardiovascular disease, a large epidemiological study has revealed. . times depending on which autoimmune condition) of developing cardiovascular disease than people without an autoimmune disorder. . T argeted prevention measures needed.

Cardiology 52

Cardiology Research Development Drugs 52

The Pharma Data

DECEMBER 12, 2020

Chief Executive Officer, Alexion , said: “For nearly 30 years Alexion has worked to develop and deliver transformative medicines to patients around the world with rare and devastating diseases. More recently, AstraZeneca has increased its efforts in immunology research and the development of medicines for immune-mediated diseases.

Development 75

Development Regulation Medicine Containment 75

Medical Xpress

FEBRUARY 16, 2023

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a major complication that increases morbidity and mortality after cardiac surgery. Most established predictive models are limited to the analysis of nonlinear relationships and do not adequately consider intraoperative variables and early postoperative variables.

Development 73

Development Cardiology 73

The Pharma Data

JANUARY 11, 2021

. “CoviLamp-PCR is providing the opportunity to dramatically expand COVID-19 testing capacity in Alberta without sacrificing accuracy,” said Dr Anmol Kapoor CEO, CardiAI/Advanced Cardiology Consultants. To book a test, members of the public can visit www.cardiai.com.

Cardiology 52

Cardiology Development 52

Drug Discovery World

NOVEMBER 25, 2022

Glenzocimab is a humanised monoclonal antibody (mAb) fragment directed against the platelet Glycoprotein VI (GPVI), which was developed by Acticor Biotech for the treatment of cardiovascular emergencies, including stroke. .

Trials 52

Trials Cardiology Antibody Drugs 52

Drug Discovery World

FEBRUARY 21, 2023

The research letter, ‘ Impact of Vaccination on Major Adverse Cardiovascular Events in Patients with COVID-19 Infection ,’ was published in the Journal of the American College of Cardiology. The post Covid-19 vaccination reduces risk of cardiac events appeared first on Drug Discovery World (DDW).

Vaccination 52

Vaccination Vaccine Cardiology Medicine 52

Scienmag

OCTOBER 8, 2020

ACC leaders will also present on management of acute coronary syndrome during conference The American College of Cardiology’s (ACC) Hani Najm Global Scholar Awards program was announced at the opening session of the Saudi Heart Association Annual Conference on Oct.

Cardiology 40

Cardiology Development Medicine 40

Velocity Clinical Research

DECEMBER 6, 2023

In addition to being one of Poland’s top recruiting sites in cardiology trials, ClinMedica also recruits patients across a broad range of therapeutic areas involving ambulatory medicine. About Grzegorz Kania, MD Grzegorz Kania, MD specializes in cardiology as well as internal and family medicine. and Europe.

Clinical Research 52

Clinical Research Research Clinical Trials Clinical Trials 52